Your funds, side by side
These are the lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust · 30 lines · as of Apr 30, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Invesco Biotechnology & Genome ETF |
|---|---|
| United Therapeutics Corp | 6.28 % |
| Illumina Inc | 5.37 % |
| Biogen Inc | 5.05 % |
| Incyte Corp | 4.91 % |
| Alnylam Pharmaceuticals Inc | 4.84 % |
| Regeneron Pharmaceuticals, Inc. | 4.77 % |
| Amgen Inc | 4.71 % |
| Gilead Sciences Inc | 4.62 % |
| BioCryst Pharmaceuticals Inc | 3.42 % |
| Catalyst Pharmaceuticals Inc | 3.30 % |
| Arrowhead Pharmaceuticals Inc | 3.28 % |
| Protagonist Therapeutics Inc | 3.22 % |
| TG Therapeutics Inc | 3.15 % |
| Royalty Pharma PLC | 3.13 % |
| CareDx Inc | 3.07 % |
| Neurocrine Biosciences Inc | 2.86 % |
| Exelixis Inc | 2.80 % |
| Bio-Techne Corp | 2.73 % |
| PTC Therapeutics Inc | 2.68 % |
| Veracyte Inc | 2.62 % |
| ACADIA Pharmaceuticals Inc | 2.59 % |
| Vericel Corp | 2.58 % |
| Halozyme Therapeutics Inc | 2.57 % |
| Repligen Corp | 2.50 % |
| Theravance Biopharma Inc | 2.50 % |
| Ionis Pharmaceuticals Inc | 2.49 % |
| BioMarin Pharmaceutical Inc | 2.45 % |
| Collegium Pharmaceutical Inc | 2.12 % |
| QIAGEN NV | 2.03 % |
| MannKind Corp | 1.45 % |
Titelia read 30 lines in these 1 funds.